Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: The DHEA and Well-Ness (DAWN) trial

Journal of the American Geriatrics Society

Volumn 56, Issue 7, 2008, Pages 1292-1298

  Kritz Silverstein, Donna ^a,b   Von Mühlen, Denise ^b   Laughlin, Gail A ^b   Bettencourt, Ricki ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Cognitive function; Dehydroepiandrosterone; DHEA; Quality of life

Indexed keywords

PLACEBO; PRASTERONE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART PALPITATION; HUMAN; LIFE SATISFACTION; MALE; MOOD; PATIENT COMPLIANCE; PROSTATE SPECIFIC ANTIGEN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUALITY; SHORT FORM 36; THORAX PAIN;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; COGNITION; DEHYDROEPIANDROSTERONE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIBIDO; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 48449102229     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01768.x     Document Type: Article

References (33)

1. Orentreich N, Brind L, Rizer R et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984 59 : 551 555.
2. Hoffman SW, Virmani S, Simkins RM et al. The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J Neurotrauma 2003 20 : 859 870.
3. Berr C, Lafont S, Debuire B et al. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological and mental status, and short-term mortality: A French community-based study. Proc Natl Acad Sci 1996 93 : 13410 13415.
4. Glei DA, Goldman N, Weinstein M et al. Dehydroepiandrosterone sulfate (DHEAS) and health: Does the relationship differ by sex? Exp Gerontol 2004 39 : 321 331.
5. Barrett-Connor E, Edelstein S. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: The Rancho Bernardo Study. J Am Geriatr Soc 1994 42 : 420 423.
6. Berkman LF, Seeman TE, Albert M et al. High, usual and impaired functioning in community dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging. J Clin Epidemiol 1993 46 : 1129 1140.
7. Barrett-Connor E, von Muhlen D, Laughlin GA et al. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. J Am Geriatr Soc 1999 47 : 685 691.
8. Sunderland T, Merril C, Harrington M et al. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 1989 2 : 570.
9. van Niekerk JK, Huppert FA, Herbert J. Salivary cortisol and DHEA: Association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 2001 26 : 591 612.
10. Mortola JF, Yen SSC. The effects of oral dehydroepiadrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990 71 : 696 704.
11. Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci 1995 774 : 128 142.
12. Wolkowitz O, Feus V, Roberts E et al. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann NY Acad Sci 1995 774 : 337 339.
13. Wolf OT, Neuman O, Hellhammer DH et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997 82 : 2363 2367.
14. Wolf OT, Kudielka BM, Hellhammer DH et al. Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor. Psychoneuroendocrinology 1998 23 : 617 629.
15. Grimley Evans J, Malouf R, Huppert F et al. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst Rev 2006;18;CD006221.
16. Barnhart KT, Freeman E, Grisso JA et al. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health related quality of life. J Clin Endocrinol Metab 1999 84 : 3896 3902.
17. Finckh A, Berner IC, Aubry-Rozier B et al. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol 2005 32 : 1336 1340.
18. Arlt W, Callies F, Allolio B. DHEA replacement in women with adrenal insufficiency - pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr Res 2000 26 : 505 511.
19. Parsons TD, Kratz KM, Thompson E et al. DHEA supplementation and cognition in postmenopausal women. Int J Neurosci 2006 116 : 141 155.
20. Bovenberg SA, van Uum SH, Hermus AR. Dehydroepiandrosterone administration in humans: Evidence based? Neth J Med 2005 63 : 300 304.
21. von Muhlen D, Laughlin GA, Kritz-Silverstein D et al. The Dehydroepiandrosterone and WellNess (DAWN) study: Research design and methods. Contemp Clin Trials 2007 28 : 153 268.
22. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatr 1987 48 : 314 318.
23. Fromm-Auch D, Yeudall LT. Normative data for the Halstead-Reitan neuropsychological tests. J Clin Neuropsychol 1983 5 : 221 238.
24. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967 5 : 135 140.
25. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia, PA : Lea and Febiger, 1982.
26. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974 24 : 1019 1025.
27. Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Arch Gen Psychiatr 1961 4 : 561 571.
28. Ware JE Jr., Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 : 473 483.
29. Wood V, Wylie ML, Sheafor B. An analysis of a short self-report measure of life satisfaction: Correlation with rater judgements. J Gerontol 1969 24 : 465 469.
30. Diener E, Emmons RA, Larson RJ et al. The satisfaction with life scale. J Pers Assess 1985 49 : 71 75.
31. Rosen R, Brown C, Heiman J et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000 26 : 191 208.
32. Rosen RC, Riley A, Wagner G et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 : 822 830.
33. von Muhlen D, Laughlin G, Kritz-Silverstein D et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults. The DAWN Trial. Osteoporosis Int 2007 Dec 15 [Epub ahead of print].